Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.
Circular Genomics has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Circular Genomics's investors include Cottonwood Technology Fund, Alzheimer's Drug Discovery Foundation, Mountain Group Capital, HIP, Poplar Grove Investors.
Circular Genomics is headquartered in Albuquerque, United States.
Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.
Circular Genomics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Circular Genomics — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/circular-genomics-albuquerque. Accessed October 22, 2026.
VCBacked. (2025). Circular Genomics — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/circular-genomics-albuquerque
{{cite web |title=Circular Genomics — Funding & Investors |url=https://www.vcbacked.co/company/circular-genomics-albuquerque |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated